Antiemetics

• 

  Subject Areas on Research

  • A comparison of ondansetron with promethazine for treating postoperative nausea and vomiting in patients who received prophylaxis with ondansetron: a retrospective database analysis. 
  • A double-blind, placebo-controlled trial of four fixed rate infusion regimens of phenylephrine for hemodynamic support during spinal anesthesia for cesarean delivery. 
  • A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study. 
  • A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting. 
  • A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting. 
  • A randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk. 
  • A randomized trial of phenylephrine infusion versus bolus dosing for nausea and vomiting during Cesarean delivery in obese women. 
  • A randomized, double-blind comparison of ondansetron versus placebo for prevention of nausea and vomiting after infratentorial craniotomy. 
  • A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. 
  • A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. 
  • Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice. 
  • American Society of Clinical Oncology 2013 top five list in oncology. 
  • An update on the management of PONV in a pediatric patient. 
  • Analgesic and antiemetic needs following minimally invasive vs open staging for endometrial cancer. 
  • Anaphylactoid reaction due to the administration of ondansetron in a pediatric neurosurgical patient. 
  • Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. 
  • Antiemetics: American Society of Clinical Oncology clinical practice guideline update. 
  • Appropriate Use of Antiemetics to Prevent Chemotherapy-Induced Nausea and Vomiting. 
  • Aprepitant for the Treatment of Chronic Refractory Pruritus. 
  • Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin. 
  • CON: Postoperative nausea and vomiting database research: limitations and opportunities. 
  • Cancer recurrence and hyperglycemia with dexamethasone for postoperative nausea and vomiting prophylaxis: more moot points? 
  • Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses. 
  • Chemotherapy-induced nausea and vomiting. 
  • Children's coping strategies for chemotherapy-induced nausea and vomiting. 
  • Clinical Practice Guideline for the Treatment of Pediatric Acute Gastroenteritis in the Outpatient Setting. 
  • Combination antiemetics: what is the evidence? 
  • Comment: Promethazine adverse events after implementation of a medication shortage interchange. 
  • Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea. 
  • Comparison of metoclopramide and promethazine for the treatment of postoperative nausea and vomiting in the post-anesthesia care unit: A retrospective database analysis. 
  • Comparison of postoperative nausea between benign and malignant brain tumor patients undergoing awake craniotomy: a retrospective analysis. 
  • Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy. 
  • Controlling emesis: evolving challenges, novel strategies. 
  • Determination of plasma concentrations of propofol associated with 50% reduction in postoperative nausea. 
  • Dexamethasone for the prophylaxis of postoperative nausea and vomiting associated with neuraxial morphine administration: a systematic review and meta-analysis. 
  • Does midline shift predict postoperative nausea in brain tumor patients undergoing awake craniotomy? A retrospective analysis. 
  • Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies. 
  • Evidence-based management of postoperative nausea and vomiting: a review. 
  • Examining racial variation in antiemetic use and post-chemotherapy health care utilization for nausea and vomiting among breast cancer patients. 
  • Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. 
  • Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. 
  • Gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, insights, and a proposed approach. 
  • Haloperidol for postoperative nausea and vomiting: are we reinventing the wheel? 
  • Haloperidol plus ondansetron versus ondansetron alone for prophylaxis of postoperative nausea and vomiting. 
  • Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting. 
  • Impact of Addition of Carboplatin AUC ≥ 4 to Antiemetic Guidelines for Triple Antiemetic Prophylaxis: A Gap in Quality of Care, Guideline Adoption, and Avoiding Acute Care. 
  • Impact of data by Fujii and colleagues on the meta-analysis of metoclopramide for antiemetic prophylaxis in women undergoing Caesarean delivery under neuraxial anaesthesia. 
  • Impact of intraoperative dexmedetomidine on postoperative analgesia following gynecologic surgery. 
  • Impact of postoperative nausea and vomiting prophylaxis with dexamethasone on the risk of recurrence of endometrial cancer. 
  • Improving Adherence to Evidence-Based Guidelines for Chemotherapy-Induced Nausea and Vomiting. 
  • Influence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate. 
  • Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. 
  • Intravenous ondansetron in established postoperative emesis in children. S3A-381 Study Group. 
  • Long-acting serotonin antagonist (Palonosetron) and the NK-1 receptor antagonists: does extended duration of action improve efficacy? 
  • Low-dose naloxone infusion for the treatment of intractable nausea and vomiting after intrathecal morphine in a parturient. 
  • Male and female rats exhibit comparable gaping behavior but activate brain regions differently during expression of conditioned nausea. 
  • Management of postdischarge nausea and vomiting after ambulatory surgery. 
  • Metoclopramide for nausea and vomiting prophylaxis during and after Caesarean delivery: a systematic review and meta-analysis. 
  • Metoclopramide-induced tardive respiratory dyskinesia. 
  • Midazolam for Anxiolysis and Postoperative Nausea and Vomiting Prophylaxis: Can We Kill Two Birds with One Stone? 
  • Midazolam--an anti-emetic? 
  • Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha. 
  • Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis. 
  • Pharmacotherapy of postoperative nausea and vomiting. 
  • Phase II study of docetaxel in advanced soft tissue sarcomas. 
  • Pilot study of aprepitant for prevention of post-ERCP pancreatitis in high risk patients: a phase II randomized, double-blind placebo controlled trial. 
  • Postoperative Pain Scores and Narcotic Use in Robotic-assisted Versus Laparoscopic Hysterectomy for Endometrial Cancer Staging. 
  • Postoperative blood sugars and use of starches - a reply. 
  • Postoperative hyperglycemia after 4- vs 8-10-mg dexamethasone for postoperative nausea and vomiting prophylaxis in patients with type II diabetes mellitus: a retrospective database analysis. 
  • Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis. 
  • Preoperative Risk Assessment to Guide Prophylaxis and Reduce the Incidence of Postoperative Nausea and Vomiting. 
  • Preventing chemotherapy-induced nausea and vomiting with netupitant/palonosetron, the first fixed combination antiemetic: current and future perspective. 
  • Pro: The Food and Drug Administration Black box warning on droperidol is not justified. 
  • Prophylaxis and treatment of the side-effects of neuraxial morphine analgesia following cesarean delivery. 
  • Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide. 
  • Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial. 
  • Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial. 
  • Safety of patients reason for FDA black box warning on droperidol. 
  • The effect of anti-emetic doses of dexamethasone on postoperative blood glucose levels in non-diabetic and diabetic patients: a prospective randomised controlled study. 
  • The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients. 
  • The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report. 
  • The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials. 
  • The evaluation of drug rechallenge: the casopitant Phase III program. 
  • The impact of postoperative nausea and vomiting prophylaxis with dexamethasone on postoperative wound complications in patients undergoing laparotomy for endometrial cancer. 
  • The next generation of antiemetics for the management of postoperative nausea and vomiting. 
  • The optimum management of nausea and vomiting during and after cesarean delivery. 
  • The prevention of emesis in plastic surgery: a randomized, prospective study. 
  • The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia. 
  • Transcutaneous acupoint electrical stimulation with the ReliefBand for the prevention of nausea and vomiting during and after cesarean delivery under spinal anesthesia. 
  • Use of Apfel Simplified Risk Score to Guide Postoperative Nausea and Vomiting Prophylaxis in Adult Patients Undergoing Same-day Surgery. 
  • Vomiting following cataract surgery. 
  • What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy.